Results 181 to 190 of about 17,499 (214)

195 - Long-term safety and efficacy of low-dose desmopressin for nocturnal polyuria in men aged over eighty

Akihiro Furuta, Takasato Igarashi, Yasuhito Suzuki, T Kimura   +3 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Differential Osteoprotegerin Kinetics after Stimulation with Desmopressin and Lipopolysaccharides In Vivo

Thrombosis and Haemostasis, 2020
Osteoprotegerin (OPG) regulates bone metabolism by reducing the activation of osteoclasts, but may also be involved in blood vessel calcification and atherosclerosis. Within endothelial cells OPG is stored in Weibel–Palade bodies (WPBs).
Nina Buchtele, Katarina D Kovacevic, C. Brostjan, M. Schwameis, H. Hayden, U. Derhaschnig, C. Firbas, B. Jilma, C. Schoergenhofer   +8 more
semanticscholar   +1 more source

Retrospective Assessment of Desmopressin Effectiveness and Safety in Patients With Antiplatelet-Associated Intracranial Hemorrhage.

Critical Care Medicine, 2019
OBJECTIVE Current international guidelines offer a conditional recommendation to consider a single dose of IV desmopressin (DDAVP) for antiplatelet-associated intracranial hemorrhage based on low-quality evidence.
E. Feldman, Gregory Meola, S. Zyck, Christopher D Miller, S. Krishnamurthy, Gregory M Cwikla, W. Darko, S. Jennings, R. Sullivan, R. Seabury   +9 more
semanticscholar   +1 more source

Comparison of desmopressin, alarm, desmopressin plus alarm, and desmopressin plus anticholinergic agents in the management of paediatric monosymptomatic nocturnal enuresis: a network meta‐analysis

BJU International, 2018
To assess the efficacy of desmopressin, alarm, desmopressin plus alarm, and desmopressin plus anticholinergic agent (AA) therapy in the management of paediatric monosymptomatic nocturnal enuresis (MNE) using a network meta‐analysis.
Pan Song, Chuiguo Huang, Yan Wang, Qingwei Wang, Wen Zhu, Yiwei Yue, Wancong Wang, Jinjin Feng, Xiangfei He, Lin-gang Cui, Tingxiang Wan, Jianguo Wen   +11 more
semanticscholar   +1 more source

Desmopressin therapy in children and adults: pharmacological considerations and clinical implications

European Journal of Clinical Pharmacology, 2022
X. Chin, S. Teo, Soo Ting Joyce Lim, Y. Ng, H. Han, F. Yap   +5 more
semanticscholar   +1 more source

Desmopressin for treating nocturia in patients with multiple sclerosis: A systematic review: A report from the Neuro‐Urology Promotion Committee of the International Continence Society (ICS)

Neurourology and Urodynamics, 2019
To systematically assess all available evidence on efficacy and safety of desmopressin for treating nocturia in patients with multiple sclerosis (MS).
V. Phé, Marc P Schneider, B. Peyronnet, Nadim Abo Youssef, L. Mordasini, E. Chartier-Kastler, L. Bachmann, T. Kessler   +7 more
semanticscholar   +1 more source

Strategies for individualized dosing of clotting factor concentrates and desmopressin in hemophilia A and B.

Therapeutic Drug Monitoring, 2019
Hemophilia A and B are hereditary bleeding disorders, caused by a deficiency of clotting factor VIII or clotting factor IX, respectively. To treat and prevent bleedings, patients can administer clotting factor concentrates (hemophilia A and B) or ...
T. Preijers, L. Schütte, M. Kruip, M. Cnossen, F. Leebeek, R. V. van Hest, R. Mathôt   +6 more
semanticscholar   +1 more source

Pediatric Pharmacology of Desmopressin in Children with Enuresis: A Comprehensive Review

Pediatric Drugs, 2020
Elke Gasthuys, L. Dossche, R. Michelet, J. Nørgaard, M. Devreese, S. Croubels, A. Vermeulen, J. Van Bocxlaer, J. Walle   +8 more
semanticscholar   +1 more source